BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2662129)

  • 1. Effect of immune globulin intravenous on opsonization of bacteria by classic and alternative complement pathways in premature serum.
    Shaio MF; Yang KD; Bohnsack JF; Hill HR
    Pediatr Res; 1989 Jun; 25(6):634-40. PubMed ID: 2662129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement.
    Verbrugh HA; Peterson PK; Nguyen BY; Sisson SP; Kim Y
    J Immunol; 1982 Oct; 129(4):1681-7. PubMed ID: 7108223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of bacterial opsonization by immune globulin intravenous: correlation of complement consumption with opsonic activity and protective efficacy.
    Yang KD; Bathras JM; Shigeoka AO; James J; Pincus SH; Hill HR
    J Infect Dis; 1989 Apr; 159(4):701-7. PubMed ID: 2494269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The key role of peptidoglycan in the opsonization of Staphylococcus aureus.
    Peterson PK; Wilkinson BJ; Kim Y; Schmeling D; Douglas SD; Quie PG; Verhoef J
    J Clin Invest; 1978 Mar; 61(3):597-609. PubMed ID: 641141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2.
    Verbrugh HA; Van Dijk WC; Peters R; Van Der Tol ME; Peterson PK; Verhoef J
    Immunology; 1979 Mar; 36(3):391-7. PubMed ID: 108204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T; Frisk A; Purvèn M; Nilsson LA
    Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participation of immunoglobulins and complement components in the intracellular killing of Staphylococcus aureus and Escherichia coli by human granulocytes.
    Leijh PC; van den Barselaar MT; Daha MR; van Furth R
    Infect Immun; 1981 Sep; 33(3):714-24. PubMed ID: 7026443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirement of extracellular complement and immunoglobulin for intracellular killing of micro-organisms by human monocytes.
    Leijh PC; van den Barselaar MT; van Zwet TL; Daha MR; van Furth R
    J Clin Invest; 1979 Apr; 63(4):772-84. PubMed ID: 374424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains.
    Verhoef J; Peterson P; Kim Y; Sabath LD; Quie PG
    Immunology; 1977 Aug; 33(2):191-7. PubMed ID: 415969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opsonic activity of immunoglobulin prepared for intravenous use.
    Hetherington SV; Giebink GS
    J Lab Clin Med; 1984 Dec; 104(6):977-86. PubMed ID: 6502004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bactericidal and opsonic activities of normal sheep serum against gram-negative bacteria.
    Mittal KR; Ingram DG
    Am J Vet Res; 1975 Aug; 36(08):1189-93. PubMed ID: 1098532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum opsonic deficiency produced by Streptococcus pneumoniae and by capsular polysaccharide antigens.
    Giebink GS; Grebner JV; Kim Y; Quie PG
    Yale J Biol Med; 1978; 51(5):527-38. PubMed ID: 34937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement-mediated phagocytosis of Pseudomonas aeruginosa.
    Peterson PK; Kim Y; Schmeling D; Lindemann M; Verhoef J; Quie PG
    J Lab Clin Med; 1978 Dec; 92(6):883-94. PubMed ID: 105067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opsonizing effect of normal cerebrospinal fluid on Staphylococcus aureus.
    Hou SC; Ho ST; Shaio MF
    J Formos Med Assoc; 1990 Nov; 89(11):977-81. PubMed ID: 1982130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of serum concentration on opsonization by the classical and alternative complement pathways.
    Tofte RW; Peterson PK; Kim Y; Quie PG
    Infect Immun; 1980 Feb; 27(2):693-6. PubMed ID: 6991425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of immune serum globulin and immune globulin intravenous with complement.
    Bing DH
    Mol Immunol; 1983 Aug; 20(8):893-900. PubMed ID: 6604863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation between serum opsonic activity for Streptococcus pneumoniae and complement function in sickle cell disease.
    Bjornson AB; Lobel JS; Harr KS
    J Infect Dis; 1985 Oct; 152(4):701-9. PubMed ID: 3930618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of antibody activity against various microorganisms in intravenous immunoglobulin preparations determined by ELISA and opsonic assay.
    Hiemstra PS; Brands-Tajouiti J; van Furth R
    J Lab Clin Med; 1994 Feb; 123(2):241-6. PubMed ID: 8301200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opsonization of bacteroides by the alternative complement pathway reconstructed from isolated plasma proteins.
    Bjornson AB; Magnafichi PI; Schreiber RD; Bjornson HS
    J Exp Med; 1987 Mar; 165(3):777-98. PubMed ID: 3819646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The septic burned patient: a model for studying the role of complement and immunoglobulins in opsonization of opportunist micro-organisms.
    Bjornson AB; Altemeier WA; Bjornson HS
    Ann Surg; 1979 Apr; 189(4):515-27. PubMed ID: 109057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.